Clinical Trials
Closed
Phase
Accrual
56%
Published
SWOG Clinical Trial Number
S0512
Phase II Trial of BAY 43-9006 (Sorafenib; NSC-724772) in Combination with Carboplatin and Paclitaxel in Patients with Metastatic Uveal Melanoma
Research Committee(s)
Melanoma
Activated
03-15-2006
Closed
01-01-2009
ClinicalTrials.gov Registry Number
NCT00329641
Closed
Phase
Accrual
68%
Published
SWOG Clinical Trial Number
S0505
Phase II Trial of BAY 43-9006 (NSC #724772) in Advanced Soft Tissue Sarcomas
Research Committee(s)
Sarcoma
Activated
03-01-2006
Closed
Phase
Accrual
55%
Published
SWOG Clinical Trial Number
S0520
Phase II Study of PXD101 (NSC-726630) in Relapsed and Refractory Aggressive B-Cell Lymphomas
Research Committee(s)
Lymphoma
Activated
01-01-2006
Closed
05-01-2009
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0433
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0509
A Phase II Study of Novel Oral Anti-Angiogenic Agent AZD2171 (NSC-732208) in Malignant Pleural Mesothelioma
Research Committee(s)
Lung Cancer
Activated
11-01-2005
Closed
04-01-2008
Closed
Phase
Accrual
72%
Published
SWOG Clinical Trial Number
S0514
Phase II Study of BAY 43-9006 (NSC #724772) as Single Agent in Unresectable or Metastatic Gallbladder Carcinoma and Cholangiocarcinoma
Research Committee(s)
Gastrointestinal Cancer
Activated
10-01-2005
Closed
01-01-2007
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0350
Phase II Trial of Cisplatin Plus Etoposide Plus Gemcitabine Plus Solumedrol (PEGS) in Peripheral T-Cell Non-Hodgkin's Lymphoma
Research Committee(s)
Lymphoma
Activated
09-15-2005
Closed
12-01-2010
Closed
Phase
Accrual
77%
Published
SWOG Clinical Trial Number
S0517
A Phase II Trial of Suberoylanilide Hydroxamic Acid (NSC-701852) for Recurrent or Primary Refractory Hodgkin's Lymphoma -
Research Committee(s)
Lymphoma
Activated
09-15-2005
Closed
08-01-2007
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0430
Phase II Trial of Simple Oral Therapy (Continuous Oral Cyclophosphamide and Capecitabine) in Patients With Metastatic Breast Cancer
Research Committee(s)
Breast Cancer
Activated
08-15-2005
Closed
09-01-2007
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0435
A Phase II Trial of BAY 43-9006 (NSC-724772) in Patients with Platinum-Treated Extensive Stage Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
07-01-2005
Closed
02-15-2007
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0515
Phase II Trial of Standard Dose Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) and Rituximab Plus Bevacizumab for Advanced Stage Diffuse Large B-Cell NHL
Research Committee(s)
Lymphoma
Activated
06-15-2005
Closed
09-15-2008
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0508
Phase II Trial of Combination Thalidomide plus Temozolomide in Patients with Metastatic Melanoma
Research Committee(s)
Melanoma
Activated
06-01-2005
Closed
01-01-2007
Closed
Phase
Accrual
29%
Published
SWOG Clinical Trial Number
S0414
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial with Molecular Correlates
Research Committee(s)
Gastrointestinal Cancer
Activated
05-01-2005
Closed
09-01-2007
Closed
Phase
Accrual
62%
Published
SWOG Clinical Trial Number
S0418
A Phase II Study of SB-715992 (NSC-727990, IND-70273) in Taxane-Resistant Androgen-Independent Metastatic Prostate Cancer
Research Committee(s)
Genitourinary Cancer
Activated
04-01-2005
Closed
05-01-2006
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0329
Phase II Study of Biweekly Gemcitabine and Paclitaxel (GEMTAX) Combination in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Research Committee(s)
Head and Neck Cancer
Activated
01-01-2005
Closed
01-01-2007
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0413
Phase II Study of GW572016 (NSC #727989) as First Line Therapy in Patients with Advanced or Metastatic Gastric Cancer
Research Committee(s)
Gastrointestinal Cancer
Activated
12-15-2004
Closed
05-15-2006
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0312
A Phase II Study of IV Gemcitabine and Oral Capecitabine in Patients with Advanced Renal Cell Cancer
Research Committee(s)
Genitourinary Cancer
Activated
12-01-2004
Closed
08-15-2005
Closed
Phase
Accrual
40%
Published
SWOG Clinical Trial Number
S0232
Double-Blinded Placebo Controlled Phase III Trial Comparing Dexamethasone (DEX) to the Combination of DEX + CC-5013 in Patients with Previously Untreated Multiple Myeloma who are Not Immediately Undergoing Autologous Stem Cell Transplant
Research Committee(s)
Myeloma
Activated
11-01-2004
Closed
05-11-2007
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0415
Cetuximab as a Second Line Therapy in Patients with Metastatic Esophageal Cancer - Phase II
Activated
10-15-2004
Closed
01-01-2007
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0420
Phase II Evaluation of BAY 43-9006 (NSC-724772) in Patients with Recurrent or Metastatic Head and Neck Cancer
Research Committee(s)
Head and Neck Cancer
Activated
10-01-2004